We are live on ! Find out more
NH

NantHealth, Inc

Delisted

NH was delisted on the 23rd of May, 2023.

38 hedge funds and large institutions have $1.17M invested in NantHealth, Inc in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% less funds holding

Funds holding: 4238 (-4)

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

49% less capital invested

Capital invested by funds: $2.31M → $1.17M (-$1.14M)

54% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 13

Holders
38
Holders Change
-4
Holders Change %
-9.52%
% of All Funds
0.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
6
Reduced
13
Closed
10
Calls
Puts
Net Calls
Net Calls Change

NH Hedge Fund Activity: Q3 2022 in Review

38 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q3 2022, worth a combined $1.17M — down 49% from $2.31M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of NH and 6 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 6 added.

The largest buyer was B. Riley Wealth Advisors, opening a new position worth an estimated $32.9K. The largest seller was Atria Wealth Solutions, exiting entirely with an estimated $205K sold.

  • 38 institutional investors held NantHealth, Inc (NH) as of Q3 2022, down from 42 in Q2 2022.
  • Funds reported $1.17M of NantHealth, Inc stock for Q3 2022, down 49% quarter-over-quarter.
  • 6 funds opened new NantHealth, Inc positions in Q3 2022 and 10 closed out, a net change of -4 holders.
  • The largest NantHealth, Inc buyer in Q3 2022 was B. Riley Wealth Advisors, an estimated $32.9K added.
  • The largest NantHealth, Inc seller in Q3 2022 was Atria Wealth Solutions, an estimated $205K sold.

Based on aggregated 13F filings for Q3 2022.